Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients with Baseline Cirrhosis or High FIB-4 Scores
It is unclear if hepatocellular carcinoma (HCC) risk declines over time after hepatitis C virus (HCV) eradication. We analyzed changes in HCC annual incidence over time following HCV eradication and identified dynamic markers of HCC risk.
Source: Gastroenterology - Category: Gastroenterology Authors: George N. Ioannou, Lauren A. Beste, Pamela K. Green, Amit G. Singal, Elliot B. Tapper, Akbar K. Waljee, Richard K. Sterling, Jordan J. Feld, David E. Kaplan, Tamar H. Taddei, Kristin Berry Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Jordan Health | Liver Cancer | Middle East Health